Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
3 reports, 3 independent
Updated Oct 10
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink and Morgan Stanley boosted Cencora's stock target price.1 source
Cencora disclosed institutional ownership changes and received analyst reports from Morgan Stanley.1 source
Keep exploring
The entities involved
-
Cencora
US drug wholesale company company
-
SEC
Slovak company
-
Morgan Stanley
U.S. investment bank
Related events
- Costco filed disclosures regarding institutional share holdings with the SEC on June 30, 2026.
- Celularity, Inc. filed with the SEC regarding its stock ownership on October 21, 2026.
- Morgan Stanley and Jefferies Financial Group raised price targets and upgraded shares for DT Midstream, Inc., following institutional filings with the SEC.
- SEC filing reported investment changes involving BLOCK and Morgan Stanley.
- Surgery Partners and Fifth Third Bancorp announced increased holdings in company stock, requiring filing with the SEC on September 8, 2026.